Brevan Howard Capital Management LP
Position in CTKB — Cytek Biosciences, Inc.
CIK 1512857
ST. HELIER, Y9
Position in CTKB
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$46,240
-$118,515 QoQ
Shares Held
10,438
-78.0% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#111
of 154 holders
Holding Since
Mar 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CTKB Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Brevan Howard Capital Management LP holds $43,939,264 across 35 Medical Devices names. CTKB ranks #35 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | STE |
STERIS plc
|
20,654 | $4,349,112 | |
| 2 | BIO |
Bio-Rad Laboratories, Inc.
|
13,718 | $4,027,741 | |
| 3 | UFPT |
Ufp Technologies Inc
|
13,400 | $3,552,742 | |
| 4 | EW |
Edwards Lifesciences Corp
|
34,889 | $3,156,058 | |
| 5 | BSX |
Boston Scientific Corp
|
68,883 | $2,939,925 | |
| 6 | SYK |
Stryker Corp
|
9,013 | $2,837,652 | |
| 7 | IRTC |
iRhythm Holdings, Inc.
|
23,847 | $2,836,600 | |
| 8 | DXCM |
Dexcom Inc
|
32,813 | $2,209,955 |
All Filings in CTKB
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $46,240 | 10,438 | Shares | Defined | 2026-08-14 | |
| 2025-09-30 | $164,755 | 47,480 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $187,414 | 55,122 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $320,614 | 79,954 | Shares | Defined | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||